First human tests begin for new Weight-Loss drug
NCT ID NCT05406115
Summary
This early-stage study tested the safety of an experimental drug called AMG 786 in healthy adults and people with obesity. Researchers gave single and multiple doses to 65 participants to check for side effects and see how the body processes the drug. The main goal was to determine if the drug is safe enough for further testing in larger trials.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OBESITY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Clinical Pharmacology of Miami, LLC
Miami, Florida, 33014, United States
-
Orange County Research Center
Tustin, California, 92780, United States
-
Translational Clinical Research LLC
Aventura, Florida, 33180, United States
Conditions
Explore the condition pages connected to this study.